PCRX

PCRX Total Liabilities

$572.01MQuarterly · USD

Period ending:

PCRX FY Total LiabilitiesUSD
PCRX FY Total Liabilities2008-12-31: $43.05M2009-12-31: $66.90M2010-12-31: $114.95M2011-12-31: $65.22M2012-12-31: $46.20M2013-12-31: $128.57M2014-12-31: $154.93M2015-12-31: $171.23M2016-12-31: $172.49M2017-12-31: $348.89M2018-12-31: $368.13M2019-12-31: $476.12M2020-12-31: $654.83M2021-12-31: $1.34B2022-12-31: $906.19M2023-12-31: $704.26M2024-12-31: $775.17M2025-12-31: $571.81M$1.34B$0.00
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PCRX total liabilities history

Total amount the company owes to creditors. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Pacira Biosciences Inc Total Liabilities — Annual fiscal periods (USD)
Period endingTotal Liabilities (USD)
571,806,000
775,168,000
704,256,000
906,190,000
1,344,945,000
654,825,000
476,121,000
368,127,000
348,888,000
172,490,000
171,231,000
154,927,000
128,571,000
46,199,000
65,221,000
114,945,000
66,903,000
43,051,000

Compare total liabilities

All PCRX financial metrics · PCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.